MEDIGOLD Sustainability Profile
MEDIGOLD, officially known as MEDIGOLD Health, is a leading provider of occupational health services headquartered in Great Britain. Founded in 1997, the company has established a strong presence across the UK, delivering comprehensive health solutions tailored to various industries. Specialising in services such as health assessments, medical screenings, and workplace wellbeing programmes, MEDIGOLD stands out for its commitment to enhancing employee health and productivity. The company has achieved significant milestones, including ISO accreditation, which underscores its dedication to quality and compliance in the healthcare sector. With a robust market position, MEDIGOLD is recognised for its innovative approach to occupational health, helping organisations navigate the complexities of employee wellbeing. Its unique blend of expertise and personalised service continues to set it apart in the competitive landscape of occupational health services.
DitchCarbon Score
How does MEDIGOLD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEDIGOLD's score of 43 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEDIGOLD's reported carbon emissions
In 2023, MEDIGOLD, headquartered in Great Britain, reported total carbon emissions of approximately 1,157,900 kg CO2e. This figure includes Scope 1 emissions of about 265,400 kg CO2e, Scope 2 emissions of around 161,500 kg CO2e, and significant Scope 3 emissions totalling approximately 731,000 kg CO2e. Within Scope 3, the largest contributors were business travel at about 269,900 kg CO2e and employee commute at approximately 396,000 kg CO2e. Despite the substantial emissions, MEDIGOLD has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. The emissions data is not cascaded from any parent organization, indicating that these figures are solely attributed to MEDIGOLD Health Consultancy Limited. Overall, while MEDIGOLD has made strides in measuring its carbon footprint, the lack of defined reduction goals highlights an opportunity for the organisation to enhance its climate action framework and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 3,840 | 0,000 |
| Scope 2 | 26,600 | 00,000 |
| Scope 3 | 1,383,590 | 0,000,000 |
How Carbon Intensive is MEDIGOLD's Industry?
How Carbon Intensive is MEDIGOLD's Location?
MEDIGOLD's Scope 3 Categories Breakdown
MEDIGOLD's Scope 3 emissions, which increased by 5% last year and increased by approximately 5% since 2022, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 60% of Scope 3 emissions.
Top Scope 3 Categories
MEDIGOLD's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEDIGOLD has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
